PRESS RELEASES
| 2012 | ||
|---|---|---|
| 15 Jan 12 |
Notice of Allowance for Patent Application in Israel
The Israel Patent Register informed the company that it has completed examination of Patent Application No. 201044 |
 |
| 12 Jan 12 |
Notice of Allowance for Patent Application in Israel - English
The Israel Patent Register informed the company that it has completed examination of Patent Application No. 201044 |
|
| 8 Jan 12 |
InsuLine is gearing up towards Sales in Germany
Appointment of Andreas Pfützner M.D. Ph.D. to Medical Director Europe; And an agreement on a clinical study for reimbursement with the IKFE Institute |
|
| 8 Jan 12 |
InsuLine is gearing up towards Sales in Germany - English
Appointment of Andreas Pfützner M.D. Ph.D. to Medical Director Europe; And an agreement on a clinical study for reimbursement with the IKFE Institute |
|
| 2011 | ||
|---|---|---|
| 21 Dec 11 |
Significant Results for InsuPatch™ in Clinical Study for FDA approval
Use of InsuPatch™ shows significant increase in blood insulin levels during the first hour after injection, compared to insulin levels without its use |
|
| 21 Dec 11 |
Significant Results for InsuPatch™ in Clinical Study for FDA approval - English
Use of InsuPatch™ shows significant increase in blood insulin levels during the first hour after injection, compared to insulin levels without its use |
|
| 3 Jul 11 |
Completion of Clinical Testing of InsuPatch
InsuLine have completed the clinical tests to receive FDA approval. |
|
| 18 Jan 11 |
Early Trails in Germany
InsuLine signs an agreement to start early tests in Germany |
|
| 2010 | ||
|---|---|---|
| 28 Dec 10 |
Appointment of Elmar Schäfer
Appointment of Elmar Schäfer to manage activities in Germany, potentially the largest market in Europe. |
|
| 9 Nov 10 |
InsuLine Begin Trails
InsuLine began carrythe trails to examine the efficacy and safety of a product the FDA - the InsuPatch. |
|